This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,840.66 contract is for the supply of Jakafi 10 mg tablet 60s to fulfill the recurring pharmaceutical needs of military healthcare facilities.
DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products and medical supplies to support the diverse medical requirements of the Department of Defense. This order is placed against that larger IDC vehicle, further solidifying DMS Pharmaceutical Group's position as a critical supplier in the federal pharmaceutical supply chain. The contract has no set-aside designation.
Generated 12/25/24, 9:15 AM